NPY
Pro-neuropeptide Y
Also known as: NPY_HUMAN, PYY4
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P01303
- Gene
- NPY
- Ensembl
- ENSG00000122585
- Chromosome
- 7
- Canonical length
- 97 aa
- Protein class
- FDA approved drug targets, Plasma proteins, Predicted secreted proteins
- Subcellular location
- Golgi apparatus
- Secretome location
- Secreted to blood
OverviewNCBI Gene
This gene encodes a neuropeptide that is widely expressed in the central nervous system and influences many physiological processes, including cortical excitability, stress response, food intake, circadian rhythms, and cardiovascular function. The neuropeptide functions through G protein-coupled receptors to inhibit adenylyl cyclase, activate mitogen-activated protein kinase (MAPK), regulate intracellular calcium levels, and activate potassium channels. A polymorphism in this gene resulting in a change of leucine 7 to proline in the signal peptide is associated with elevated cholesterol levels, higher alcohol consumption, and may be a risk factor for various metabolic and cardiovascular diseases. The protein also exhibits antimicrobial activity against bacteria and fungi. [provided by RefSeq, Oct 2014]
Canonical amino-acid sequenceUniProt
97 residues, UniProt reviewed canonical sequence.
>P01303|NPY
1 MLGNKRLGLS GLTLALSLLV CLGALAEAYP SKPDNPGEDA PAEDMARYYS ALRHYINLIT
61 RQRYGKRSSP ETLISDLLMR ESTENVPRTR LEDPAMWLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NPY can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.53
- Highest tissue expression
- 348 nTPM
Expression across tissuesHPA
Tissue
- prostate: 348 nTPM
- basal ganglia: 297 nTPM
- cerebral cortex: 132 nTPM
- amygdala: 121 nTPM
- adrenal gland: 115 nTPM
- hypothalamus: 100 nTPM
Single-cell type
- prostatic glandular cells: 826 nCPM
- pancreatic islet cells: 134 nCPM
- brain inhibitory neurons: 66 nCPM
- adrenal medulla cells: 53 nCPM
- other brain neurons: 34 nCPM
- salivary ionocytes: 25 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- hypothalamus: 885 nTPM
- basal ganglia: 100 nTPM
- cerebral cortex: 54 nTPM
- white matter: 46 nTPM
- amygdala: 45 nTPM
- midbrain: 31 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about NPY.
Disease | ImmuneIEDB
Conditions an epitope on NPY was assayed in.
- type 1 diabetes mellitus T cell
- prediabetes syndrome T cell
ReferencesPubMed · IEDB
Publications for NPY from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
3 publications
- Anti-neuropeptide Y plasma immunoglobulins in relation to mood and appetite in depressive disorder.
2012 · Psychoneuroendocrinology · RCR 0.5 · 15 citations - Neuropeptide Y autoantibodies in patients with long-term type 1 and type 2 diabetes and neuropathy.
2013 · J Diabetes Complications · RCR 0.3 · 8 citations - Neuropeptide Y is a minor autoantigen in newly diagnosed type 1 diabetes patients.
2015 · Pediatr Diabetes · RCR 0.2 · 5 citations
Reference: T cellIEDB
6 publications
- Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion.
2016 · Science · RCR 13.5 · 434 citations - Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes.
2016 · Nat Med · RCR 9.1 · 276 citations - Hybrid Insulin Peptides Are Autoantigens in Type 1 Diabetes.
2019 · Diabetes · RCR 2.8 · 75 citations - T-cell responses to hybrid insulin peptides prior to type 1 diabetes development.
2021 · Proc Natl Acad Sci U S A · RCR 2.2 · 42 citations - A structural basis of T cell cross-reactivity to native and spliced self-antigens presented by HLA-DQ8.
2024 · J Biol Chem · RCR 1.3 · 9 citations
Show 1 more
- Mapping T Cell Responses to Native and Neo-Islet Antigen Epitopes in at Risk and Type 1 Diabetes Subjects.
2021 · Front Immunol · RCR 0.8 · 13 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.08
- gnomAD pLI
- 0.14
- gnomAD missense Z
- 0.64
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adult feeding behavior
- central nervous system neuron development
- cerebral cortex development
- chemical synaptic transmission
- developmental growth
- drinking behavior
- feeding behavior
- G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger
- intestinal epithelial cell differentiation
- monocyte activation
- negative regulation of acute inflammatory response to antigenic stimulus
- negative regulation of blood pressure
- neuron projection development
- neuropeptide signaling pathway
- positive regulation of appetite
- positive regulation of cell population proliferation
- positive regulation of cell-substrate adhesion
- positive regulation of dopamine metabolic process
- positive regulation of eating behavior
- positive regulation of ERK1 and ERK2 cascade
- positive regulation of nitric oxide metabolic process
- regulation of presynaptic cytosolic calcium ion concentration
- regulation of synaptic vesicle exocytosis
- synaptic signaling via neuropeptide
- regulation of nerve growth factor production
- short-day photoperiodism
Molecular functions
- calcium channel regulator activity
- G protein-coupled receptor activity
- neuropeptide hormone activity
- neuropeptide Y receptor binding
- signaling receptor binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NPY as an antibody target. Whether an autoantibody or antibody against NPY could matter depends on whether native NPY is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NPY is annotated as secreted, so native NPY circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label NPY as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...